Methylone

DB19192InvestigationalSmall molecule

Methylone is under investigation in clinical trial NCT05741710 (A Study to Assess the use of Methylone in the Treatment of PTSD).

Mechanism: Pharmacologically active on Sodium-dependent noradrenaline transporter, Sodium-dependent dopamine transporter, and Sodium-dependent serotonin transporter
Curator reviewed
Formula / weight: C₁₁H₁₃NO₃ · 207.229 g/mol (avg)
Also known as: 1-propanone, 1-(1,3-benzodioxol-5-yl)-2-(methylamino)- · 3,4-methylenedioxy-n-methylcathinone · MDMC · Methylenedioxymethcathinone
Code names: J899.632F · TSND-201

Resolves to

Compound

Clinical / RWD

Structure

InChIKeyVKEQBMCRQDSRET-UHFFFAOYSA-NSMILESCNC(C)C(=O)C1=CC=C2OCOC2=C1

Targets

What you can answer from here — as of July 09, 2026

3Protein targetsEach mapped to UniProt, with action and pharmacological action

Listed above

5Clinical trialsPhase, status and sponsor resolved per trial

8+ReferencesStructured and connected to the statements they support

Which drugs share a target with Methylone, and which of those have an active Phase 3 trial?

Create a free account or log in to explore the full data card.